At the news
? NEUTRALIMPACT 3/10 144 filed Oct 30, 2026 at 14:55 ET
Lilly Endowment Inc., the company's largest shareholder with a $108.4B stake, filed a Form 144 notice of intent to sell 295,000 shares of Eli Lilly common stock, valued at approximately $405 million based on the filing date. The endowment has been actively selling shares in recent months, with prior sales totaling over $1.1 billion since August 2026. This is a routine portfolio rebalancing by a long-term charitable holder, not an insider trading signal.
- Lilly Endowment Inc. intends to sell 295,000 shares of Eli Lilly common stock.
- Estimated value of the proposed sale is $405,241,500 based on the filing.
- The endowment has sold approximately 1,007,403 shares in four separate transactions since August 2026, totaling over $1.1 billion.
- Lilly Endowment is the largest institutional holder with a $108.4B stake as of Q2 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access